Home›People›Michael Kokesh
MK

Michael Kokesh

President & Chief Executive Officer at ViCardia Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing May 21, 2026·Suggest an edit

About Michael Kokesh

Michael Kokesh is a president & chief executive officer at ViCardia Therapeutics.

Experience

This experience comes from Michael Kokesh's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Kokesh in the role, so the role may have started earlier or lasted longer.

ViCardia Therapeutics, Inc. Current
President & Chief Executive Officer
2017 – Present · San Francisco, CA
Develops a cellular delivery platform for people with chronic and rare diseases.
Ramparts Asset Management Company, LLC Current
Managing Director
2009 – Present
Ecron Acunova
Strategic Advisor
2008 – 2015
Morgan Stanley & Co., Inc.
Registered Investment Advisor
2008 – 2009
AcuNova Life Sciences, Inc.
President & CEO
2005 – 2008
Gentiae Clinical Research
President & CEO; Founder
2000 – 2005
Ischemia Research & Education Foundation
President & CEO
2000 – 2001
Raytel Medical Corporation
Vice President - General Counsel
1996 – 2001
National Reproductive Medical Centers
Co-Founder, VP-General Counsel, Member Board of Directors
1991 – 1996

Sources

  1. SECViCardia Therapeutics, Inc. Form D, filed May 21, 2026